1. J05 Interim results from cohort 1 of the double-blind, dose-escalation phase I/II clinical trial of amt-130 (HD-genetrx-1) for early-stage huntington's disease (HD). (12th September 2022) Authors: Furr Stimming, Erin; Sung, Victor; Testa, Claudia; Kostyk, Sandra; Ross, Christopher A; Samii, Ali; Geschwind, Michael D; Hall, Deborah; Dayalu, Praveen; Lonser, Russell; Elder, Brad; Larson, Paul S; Cooper, David L; Clarkin, Marcie; Ali, Talaha M; Dolmetsch, Ricardo E Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93(2022)Supplement 1 Page Start: A95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Microglia Activation in Basal Ganglia Is a Late Event in Huntington Disease Pathophysiology. Issue 3 (May 2021) Authors: Rocha, Natalia P.; Charron, Odelin; Latham, Leigh B.; Colpo, Gabriela D.; Zanotti-Fregonara, Paolo; Yu, Meixiang; Freeman, Leorah; Furr Stimming, Erin; Teixeira, Antonio L. Journal: Neurology Issue: Volume 8:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Sex Differences in Huntington's Disease: Evaluating the Enroll‐HD Database. Issue 3 (8th March 2021) Authors: Hentosh, Samantha; Zhu, Liang; Patino, Jorge; Furr, J. Weldon; Rocha, Natalia P.; Furr Stimming, Erin Journal: Movement disorders clinical practice Issue: Volume 8:Issue 3(2021) Page Start: 420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗